Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 Apr;16(1):155–162. doi: 10.1128/iai.16.1.155-162.1977

Complications and immunological studies of measles virus infection in antithymocyte-treated hamsters.

N E Cremer, S J Hagens, D O Taylor, E H Lennette
PMCID: PMC421503  PMID: 301505

Abstract

A study was done to investigate possible late central nervous system (CNS) complications of latent measles infection in hamsters. Signs of CNS disease, consisting of myoclonus and paralysis, occurred in some weanling hamsters inoculated intraperitoneally at 3 or 9 days of age with antithymocyte serum (ATS) and measles virus, but no late complications in adult life attributable to measles virus were seen. A single series of ATS injections plus an injection of measles virus resulted in sustained antibody formation postulated due to establishment of a latent viral infection, whereas similar treatment with normal rabbit serum plus virus caused no or minimal antibody response. The majority of hamsters receiving ATS as newborns and ATS plus virus as weanlings also did not produce antibody. This differential effect of ATS may be due to combined elimination of suppressor and helper cells in the latter ATS-treated group and of suppressor cells only in the former ATS-treated group. Cellular immunity could not be evaluated since lymphocytes from inoculated and uninoculated hamsters released equal and variable amounts of 51Cr for both infected and noninfected labeled, allogeneic hamster target cells.

Full text

PDF
155

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M., Cendrowski W. Multiple sclerosis and childhood infections. Neurology. 1976 Mar;26(3):201–204. doi: 10.1212/wnl.26.3.201. [DOI] [PubMed] [Google Scholar]
  2. BURNSTEIN T., JENSEN J. H., WAKSMAN B. H. THE DEVELOPMENT OF A NEUROTROPIC STRAIN OF MEASLES VIRUS IN HAMSTERS AND MICE. J Infect Dis. 1964 Jun;114:265–272. doi: 10.1093/infdis/114.3.265. [DOI] [PubMed] [Google Scholar]
  3. Barbanti-Brodano G., Oyanagi S., Katz M., Koprowski H. Presence of 2 different viral agents in brain cells of patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med. 1970 May;134(1):230–236. doi: 10.3181/00379727-134-34765. [DOI] [PubMed] [Google Scholar]
  4. Barth R. F., Singla O., Liu C. Suppressor T cells and host resistance to tye 111 pneumococcus after treatment with antilymphocyte serum. Infect Immun. 1975 Dec;12(6):1307–1312. doi: 10.1128/iai.12.6.1307-1312.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Byington D. P., Johnson K. P. Experimental subacute sclerosing panencephalitis in the hamster: correlation of age with chronic inclusion-cell encephalitis. J Infect Dis. 1972 Jul;126(1):18–26. doi: 10.1093/infdis/126.1.18. [DOI] [PubMed] [Google Scholar]
  6. Byington D. P., Johnson K. P. Subacute sclerosing panencephalitis virus in immunosuppressed adult hamster. Lab Invest. 1975 Jan;32(1):91–97. [PubMed] [Google Scholar]
  7. Gerson K. L., Haslam R. H. Subtle immunologic abnormalities in four boys with subacute sclerosing panencephalitis. N Engl J Med. 1971 Jul 8;285(2):78–82. doi: 10.1056/NEJM197107082850203. [DOI] [PubMed] [Google Scholar]
  8. Kibler R., Cremer N. E. Antithymocyte serum treatment of hamsters inoculated with a measles virus isolated from a patient with subacute sclerosing panencephalitis. Immunol Commun. 1973;2(3):303–321. doi: 10.3109/08820137309022802. [DOI] [PubMed] [Google Scholar]
  9. Kibler R., Deller A., ter Meulen V. Cytotoxic antibody activity in measles and subacute sclerosing panencephalitis (SSPE) infection. Med Microbiol Immunol. 1974;160(2-3):179–190. doi: 10.1007/BF02121725. [DOI] [PubMed] [Google Scholar]
  10. Klajman A., Sternbach M., Ranon L., Drucker M., Geminder D., Sadan N. Impaired delayed hypersensitivity in subacute sclerosing panencephalitis. Acta Paediatr Scand. 1973 Sep;62(5):523–526. doi: 10.1111/j.1651-2227.1973.tb08150.x. [DOI] [PubMed] [Google Scholar]
  11. Kolar O. Measles and subacute sclerosing panencephalitis. Lancet. 1968 Dec 7;2(7580):1242–1242. doi: 10.1016/s0140-6736(68)91719-4. [DOI] [PubMed] [Google Scholar]
  12. Kreth W. H., Käckell M. Y., ter Meulen V. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE. J Immunol. 1975 Mar;114(3):1042–1046. [PubMed] [Google Scholar]
  13. Levey R. H., Medawar P. B. Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A. 1966 Oct;56(4):1130–1137. doi: 10.1073/pnas.56.4.1130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mizutani H., Gerson K. L., Haslam R. H. Skin-test reactions in patients with SSPE. N Engl J Med. 1972 Jan 6;286(1):48–48. doi: 10.1056/NEJM197201062860120. [DOI] [PubMed] [Google Scholar]
  15. Moulias R. L., Reinert P., Goust J. M. Immunologic abnormalities in subacute sclerosing panencephalitis. N Engl J Med. 1971 Nov 4;285(19):1090–1090. [PubMed] [Google Scholar]
  16. Steele R. W., Fuccillo D. A., Hensen S. A., Vincent M. M., Bellanti J. A. Specific inhibitory factors of cellular immunity in children with subacute sclerosing panencephalitis. J Pediatr. 1976 Jan;88(1):56–62. doi: 10.1016/s0022-3476(76)80727-5. [DOI] [PubMed] [Google Scholar]
  17. Thurman G. B., Ahmed A., Strong D. M., Knudsen R. C., Grace W. R., Sell K. W. Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines. J Exp Med. 1973 Oct 1;138(4):839–846. doi: 10.1084/jem.138.4.839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Valdimarsson H., Agnarsdottir G., Lachmann P. J. Cellular immunity in subacute sclerosing panencephalitis. Proc R Soc Med. 1974 Nov;67(11):1125–1129. doi: 10.1177/003591577406701117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vandvik B. Immunological studies in subacute sclerosing panencephalitis. Acta Neurol Scand. 1970;46(Suppl):232–232. doi: 10.1111/j.1600-0404.1970.tb02203.x. [DOI] [PubMed] [Google Scholar]
  20. Zinkernagel R. M., Doherty P. C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 1974 Apr 19;248(5450):701–702. doi: 10.1038/248701a0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES